Cargando…

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review

BACKGROUND: Despite the burden of schizophrenia and bipolar disorder in the Chinese population, country-specific data to guide practitioners regarding antipsychotic therapy are lacking. The primary aim of this systematic review was to examine evidence of the efficacy, effectiveness, and safety of ol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Hai Bo Haber, Liu, Li, Zhang, Hena, Montgomery, William, Treuer, Tamás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037301/ https://www.ncbi.nlm.nih.gov/pubmed/24876777 http://dx.doi.org/10.2147/NDT.S58096

Ejemplares similares

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
por: Novick, Diego, et al.
Publicado: (2017)

Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties
por: Zhao, Jingping, et al.
Publicado: (2014)

Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
por: Montgomery, William, et al.
Publicado: (2015)

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
por: Montgomery, William, et al.
Publicado: (2014)

Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
por: Ye, Wenyu, et al.
Publicado: (2014)

Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
por: Montgomery, William, et al.
Publicado: (2012)

Review of olanzapine in the management of bipolar disorders
por: Narasimhan, Meera, et al.
Publicado: (2007)

Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study
por: Novick, Diego, et al.
Publicado: (2015)

The personal, societal, and economic burden of schizophrenia in the People’s Republic of China: implications for antipsychotic therapy
por: Montgomery, William, et al.
Publicado: (2013)

Olanzapine Discontinuation Emergent Recurrence in Bipolar Disorder
por: Arora, Manu, et al.
Publicado: (2014)

Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study
por: Kutzelnigg, Alexandra, et al.
Publicado: (2014)

The potential role of appetite in predicting weight changes during treatment with olanzapine
por: Case, Michael, et al.
Publicado: (2010)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao, Keming, et al.
Publicado: (2013)

An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report
por: Hobbs, David, et al.
Publicado: (2013)

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
por: Maloney, Ann E, et al.
Publicado: (2010)

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
por: Treuer, Tamás, et al.
Publicado: (2016)

Olanzapine induced tardive dystonia in case of adolescent bipolar disorder
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2009)

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
por: Wang, Gang, et al.
Publicado: (2016)

Sex differences in the course of schizophrenia across diverse regions of the world
por: Novick, Diego, et al.
Publicado: (2016)

Delirium Associated with Olanzapine Therapy in an Elderly Male with Bipolar Affective Disorder
por: Sharma, Ravi C., et al.
Publicado: (2010)

Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration
por: Zain, Mohd Aizat, et al.
Publicado: (2012)

High-dose olanzapine in treatment-resistant schizophrenia: a systematic review
por: Gannon, Louisa, et al.
Publicado: (2023)

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
por: Zhou, Wei, et al.
Publicado: (2019)

Cognitive Impairment in Bipolar Disorder and Schizophrenia: A Systematic Review
por: Vöhringer, Paul A., et al.
Publicado: (2013)

High-dose olanzapine in treatment resistant schizophrenia. A case report and literature review
por: Clarke, Ciara, et al.
Publicado: (2021)

Effect Of Risperidone And Olanzapine On The Metabolic Profile Of Drug Naïve Bipolar Disorder Patients.
por: Gupta, Gajal, et al.
Publicado: (2022)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group
por: Xu, Lei, et al.
Publicado: (2015)

Efficacy of Olanzapine in Anxiety Dimension of Schizophrenia: A Systematic Review of Randomized Controlled Trials
por: Crapanzano, Calogero, et al.
Publicado: (2022)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literature
por: Birur, Badari, et al.
Publicado: (2017)

A systematic review of the literature on telepsychiatry for bipolar disorder
por: Farrell, Abigail, et al.
Publicado: (2022)

Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia
por: Li, Anning, et al.
Publicado: (2018)

The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature
por: Saudemont, G., et al.
Publicado: (2020)

Pareidolia in Schizophrenia and Bipolar Disorder
por: Abo Hamza, Eid G., et al.
Publicado: (2021)

S226. A STUDY COMPARING WEIGHT GAIN FROM ALKS 3831 TO OLANZAPINE IN EARLY-ILLNESS YOUNG ADULTS WITH SCHIZOPHRENIFORM, SCHIZOPHRENIA, OR BIPOLAR I DISORDER
por: Simmons, Adam, et al.
Publicado: (2018)

Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
por: Kulkarni, Gajanan, et al.
Publicado: (2012)

Comparison of Mental Health Resources Used by Patients With Bipolar Disorder Treated With Risperidone, Olanzapine, or Quetiapine
por: Gianfrancesco, Frank, et al.
Publicado: (2005)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia
por: Lu, Mong-Liang, et al.
Publicado: (2016)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5kh6surg0dp22fegjt2fgkkr8f